Replies to post #271506 on Innovation Pharmaceuticals Inc (IPIX)

[Phoenix300]

B-OM interim results versus end of trial results were not similar. It really seemed to take the wind out of the sail here.

It’s too bad.

Now the share authorization increase proposal from 300m to 600m.

A case study.